In our study, utilising ALI and xenograft models, we observed elevated ACE2 expression in BSCs from COVID‐19 patients, the primary receptor for SARS‐CoV‐2 and a key factor linked to disease severity [25]. This evidence concerns the gene ACE2 and COVID-19.